Septerna, Inc. (SEPN) stock
SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30195% above fair value
$42.60+0.74 (+1.77%)
Close on Nov 13, 2026Market cap $1.99BP/E –Yield –
Septerna profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Septerna's profit margin for the twelve months ending Sep 30, 2026 was -61.3%. For fiscal 2025 it was -106.4%, against -6678.9% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -106.4% | +6572.5 |
| FY2024 | Dec 31, 2024 | -6678.9% | −9447.1 |
| FY2023 | Dec 31, 2023 | 2768.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -140.8% | −178.9 |
| Q2 FY2026 | Jun 30, 2026 | -48.7% | +20823.5 |
| Q1 FY2026 | Mar 31, 2026 | -32.6% | +9773.8 |
| Q4 FY2025 | Dec 31, 2025 | -44.5% | +9704.5 |
| Q3 FY2025 | Sep 30, 2025 | 38.0% | +11698.8 |
| Q2 FY2025 | Jun 30, 2025 | -20872.3% | −16410.1 |
| Q1 FY2025 | Mar 31, 2025 | -9806.4% | −5359.4 |
| Q4 FY2024 | Dec 31, 2024 | -9749.1% | −39320.2 |
| Q3 FY2024 | Sep 30, 2024 | -11660.8% | +21505.9 |
| Q2 FY2024 | Jun 30, 2024 | -4462.2% | – |
| Q1 FY2024 | Mar 31, 2024 | -4447.0% | – |
| Q4 FY2023 | Dec 31, 2023 | 29571.2% | – |
| Q3 FY2023 | Sep 30, 2023 | -33166.7% | – |
See a number that looks wrong?